Search

This Data Spotlight reviews national and state-level enrollment trends as of March 2016 and examines variation in enrollment by plan type and firm. It analyzes the most recent data on premiums, out-of-pocket limits, Part D cost-sharing for drugs, and plans’ quality ratings for Medicare Advantage enrollees.

This Kaiser Family Foundation/New York Times survey explores the attitudes of Chicago residents on the political, economic, and social issues confronting their city. It probes deeply into the views and experiences of Chicago’s Black, White, and Hispanic residents, including issues of crime and policing, race relations, and life in Chicago’s neighborhoods.

Strong Support for U.S. Role in Combatting Zika At Home and Abroad When it comes to world affairs, majorities of Americans list fighting terrorism (64%), protecting human rights (60%), and protecting the environment and fighting climate change (51%) as top priorities for the president and Congress, finds a new Kaiser…

The Affordable Care Act’s (ACA) major coverage reforms have created new pathways to insurance coverage for millions of Americans, including those with HIV. How have these changes affected coverage and access to care for people with HIV? Who has gained new coverage and who has been left out? On May 4 at 9:30 a.m. ET, the Kaiser Family Foundation held a policy briefing to discuss these questions with a panel of experts.

The U.S. government has a long history of supporting efforts to improve the health of women and families around the world. While many U.S. programs address women and family health generally, several are focused on them directly, including: maternal and child health (MCH), which includes immunization activities; family planning and reproductive health (FP/RH); and nutrition. This overview paper presents key findings for accompanying papers examining U.S funding for each of these sectors. They look at funding trends over time, the top country recipients of aid, the share of funding provided to the sector within the larger U.S. global health funding portfolio, and the role of the U.S. as a donor in the context of overall donor support.

The U.S. government has a long history of supporting global efforts to improve nutrition and is the largest donor to nutrition efforts in the world. This brief provides an overview of U.S. support for nutrition, including trends in funding and top country recipients and places the U.S. within the larger context of overall donor support for the sector.

The U.S. government has a long history of supporting international maternal and child health (MCH) efforts, including global immunization activities, and is the largest donor government to MCH activities in the world. This brief provides an overview of U.S. funding for MCH, including trends in bilateral and multilateral funding and top country recipients of U.S. funding, and places the U.S. within the larger context of overall donor support for the sector.

The U.S. government has supported international family planning and reproductive health (FP/RH) efforts for 50 years and is one of the largest donors to FP/RH in the world. This brief provides an overview of U.S. funding for FP/RH, including trends in bilateral and multilateral funding and top country recipients of U.S. funding, and places the U.S. within the larger context of overall donor support for the sector.

The 2016 Survey of Americans on the U.S. Role in Global Health is the latest in a series of surveys designed, conducted, and analyzed by the Kaiser Family Foundation in order to shed light on the American public’s perceptions, knowledge, and attitudes about the role of the United States in efforts to improve health for people in developing countries. This most recent survey updates trends on Americans’ perceptions of the most urgent problems facing developing countries, views on U.S. spending on health, and U.S. priorities for women’s health in developing countries. It also explores new questions on Americans’ awareness of the Zika virus outbreak and recent U.S. efforts to combat the outbreak both at home and in developing countries.

Using Medicaid State Drug Utilization Data, this brief presents the 50 most costly drugs before rebates used by the Medicaid program over the January 2014 through June 2015 period. It then examines reasons why these drugs are so costly; explores case studies on opioids, hepatitis C drugs, and the drug Abilify; and considers policy implications.